Cargando…

The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice

INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD Exacerbation Recognition Tool (CERT). METHODS: The study was run across three sites in China in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Paul W, Wang, Chanzheng, Chen, Ping, Chen, Liping, Wang, Daoxin, Xia, Junbo, Yang, Yang, Wang, Yingyu, Ma, Qianli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789323/
https://www.ncbi.nlm.nih.gov/pubmed/35087270
http://dx.doi.org/10.2147/COPD.S337644
_version_ 1784639741805723648
author Jones, Paul W
Wang, Chanzheng
Chen, Ping
Chen, Liping
Wang, Daoxin
Xia, Junbo
Yang, Yang
Wang, Yingyu
Ma, Qianli
author_facet Jones, Paul W
Wang, Chanzheng
Chen, Ping
Chen, Liping
Wang, Daoxin
Xia, Junbo
Yang, Yang
Wang, Yingyu
Ma, Qianli
author_sort Jones, Paul W
collection PubMed
description INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD Exacerbation Recognition Tool (CERT). METHODS: The study was run across three sites in China in patients who had an exacerbation within the previous year. Step 1: focus group qualitative study (total 48 patients) captured symptoms associated with an exacerbation. Step 2: cognitive debriefing to ensure items were appropriately worded. Step 3: 150 patients (69 years, 21% female, FEV(1) 63% predicted, CAT 15, 2 exacerbations in previous year) completed a questionnaire composed of the items from Steps 1 and 2 using two response options – severity during an exacerbation and magnitude of change from usual state. Responses were analysed in terms of frequency and tested for influence of demographic factors. Exploratory factor analysis (EFA) identified key domains. Using these results, an expert panel guided choice of items that formed the CERT. RESULTS: Following Steps 1 and 2, 29 candidate items were selected for Step 3. Response rates with the two response options were very similar. There was minimal influence of demographic factors on response to the items. EFA using the 11 items with the highest response rates identified two principal factors, Factor 1: breathlessness and activity limitation (79.1% of variance), Factor 2: cough and sputum (20.9% of variance). Five items were selected for the CERT based on response rate and EFA factor loading: worsening cough, increased sputum volume, shortness of breath, laborious breathing, and limitation of motion. Sensitivity analysis suggested that worsening of two or more symptoms had good sensitivity and specificity for the presence of an exacerbation. DISCUSSION: The CERT is an evidence-based tool to provide patients with simple-to-follow guidance about when to seek medical attention when their COPD symptoms worsen.
format Online
Article
Text
id pubmed-8789323
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87893232022-01-26 The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice Jones, Paul W Wang, Chanzheng Chen, Ping Chen, Liping Wang, Daoxin Xia, Junbo Yang, Yang Wang, Yingyu Ma, Qianli Int J Chron Obstruct Pulmon Dis Original Research INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD Exacerbation Recognition Tool (CERT). METHODS: The study was run across three sites in China in patients who had an exacerbation within the previous year. Step 1: focus group qualitative study (total 48 patients) captured symptoms associated with an exacerbation. Step 2: cognitive debriefing to ensure items were appropriately worded. Step 3: 150 patients (69 years, 21% female, FEV(1) 63% predicted, CAT 15, 2 exacerbations in previous year) completed a questionnaire composed of the items from Steps 1 and 2 using two response options – severity during an exacerbation and magnitude of change from usual state. Responses were analysed in terms of frequency and tested for influence of demographic factors. Exploratory factor analysis (EFA) identified key domains. Using these results, an expert panel guided choice of items that formed the CERT. RESULTS: Following Steps 1 and 2, 29 candidate items were selected for Step 3. Response rates with the two response options were very similar. There was minimal influence of demographic factors on response to the items. EFA using the 11 items with the highest response rates identified two principal factors, Factor 1: breathlessness and activity limitation (79.1% of variance), Factor 2: cough and sputum (20.9% of variance). Five items were selected for the CERT based on response rate and EFA factor loading: worsening cough, increased sputum volume, shortness of breath, laborious breathing, and limitation of motion. Sensitivity analysis suggested that worsening of two or more symptoms had good sensitivity and specificity for the presence of an exacerbation. DISCUSSION: The CERT is an evidence-based tool to provide patients with simple-to-follow guidance about when to seek medical attention when their COPD symptoms worsen. Dove 2022-01-21 /pmc/articles/PMC8789323/ /pubmed/35087270 http://dx.doi.org/10.2147/COPD.S337644 Text en © 2022 Jones et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jones, Paul W
Wang, Chanzheng
Chen, Ping
Chen, Liping
Wang, Daoxin
Xia, Junbo
Yang, Yang
Wang, Yingyu
Ma, Qianli
The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
title The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
title_full The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
title_fullStr The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
title_full_unstemmed The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
title_short The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
title_sort development of a copd exacerbation recognition tool (cert) to help patients recognize when to seek medical advice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789323/
https://www.ncbi.nlm.nih.gov/pubmed/35087270
http://dx.doi.org/10.2147/COPD.S337644
work_keys_str_mv AT jonespaulw thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT wangchanzheng thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT chenping thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT chenliping thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT wangdaoxin thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT xiajunbo thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT yangyang thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT wangyingyu thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT maqianli thedevelopmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT jonespaulw developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT wangchanzheng developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT chenping developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT chenliping developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT wangdaoxin developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT xiajunbo developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT yangyang developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT wangyingyu developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice
AT maqianli developmentofacopdexacerbationrecognitiontoolcerttohelppatientsrecognizewhentoseekmedicaladvice